INFINITT Healthcare Co., Ltd. (KOSDAQ:071200)

INFINITT Healthcare Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	107,093	101,570	88,476	88,286	78,170	70,069
Other Revenue	-	-	-0	-	-0	-
Revenue	107,093	101,570	88,476	88,286	78,170	70,069
Revenue Growth (YoY)	15.51%	14.80%	0.21%	12.94%	11.56%	-5.65%
Cost of Revenue	38,524	37,599	36,620	34,754	32,371	26,891
Gross Profit	68,569	63,971	51,855	53,532	45,799	43,179
Selling, General & Admin	38,911	37,969	34,086	33,565	27,952	26,493
Research & Development	8,405	9,208	8,635	8,039	7,378	5,757
Other Operating Expenses	401.62	277.76	254.94	268.2	272.09	234.81
Operating Expenses	51,824	50,281	45,226	45,675	38,691	36,008
Operating Income	16,744	13,691	6,629	7,857	7,108	7,171
Interest Expense	-123.85	-131.75	-132.38	-121.79	-118.18	-139.36
Interest & Investment Income	2,701	2,982	1,779	1,164	743.52	419.58
Earnings From Equity Investments	20.94	-38.63	100.77	22.47	65.12	-163.71
Currency Exchange Gain (Loss)	-375.45	3,627	675.15	-698.68	1,836	-1,187
Other Non Operating Income (Expenses)	339.94	85.79	-12.43	320.9	2,311	235.35
EBT Excluding Unusual Items	19,307	20,215	9,039	8,544	11,946	6,336
Gain (Loss) on Sale of Investments	13,299	34,039	15,210	-11,648	14,071	492.58
Gain (Loss) on Sale of Assets	11.6	-30.97	-5.79	0.46	-1.11	-3.72
Asset Writedown	-0.08	-0.08	-	-	-	-122.76
Other Unusual Items	-	-	20.38	8.84	8.98	1,611
Pretax Income	32,617	54,223	24,264	-3,095	26,025	8,312
Income Tax Expense	4,789	7,516	3,972	-3,256	3,386	1,645
Earnings From Continuing Operations	27,828	46,707	20,292	160.93	22,639	6,667
Earnings From Discontinued Operations	-1,561	-2,066	-818.3	-	-	-
Net Income to Company	26,267	44,642	19,474	160.93	22,639	6,667
Minority Interest in Earnings	-271.6	-718.19	-335.66	-29.36	17.65	15.49
Net Income	25,995	43,923	19,139	131.57	22,656	6,683
Net Income to Common	25,995	43,923	19,139	131.57	22,656	6,683
Net Income Growth	-4.33%	129.50%	14446.72%	-99.42%	239.02%	-7.79%
Shares Outstanding (Basic)	24	24	24	24	24	24
Shares Outstanding (Diluted)	24	24	24	24	24	24
Shares Change (YoY)	-	-	-	-0.19%	0.19%	-
EPS (Basic)	1066.41	1801.88	785.12	5.40	929.44	274.16
EPS (Diluted)	1066.41	1801.88	785.12	5.00	928.00	274.00
EPS Growth	-4.33%	129.50%	15602.46%	-99.46%	238.69%	-7.74%
Free Cash Flow	11,150	11,664	9,563	8,281	15,424	14,955
Free Cash Flow Per Share	457.42	478.50	392.29	339.72	631.52	613.50
Gross Margin	64.03%	62.98%	58.61%	60.63%	58.59%	61.62%
Operating Margin	15.63%	13.48%	7.49%	8.90%	9.09%	10.23%
Profit Margin	24.27%	43.24%	21.63%	0.15%	28.98%	9.54%
Free Cash Flow Margin	10.41%	11.48%	10.81%	9.38%	19.73%	21.34%
EBITDA	19,173	16,284	9,127	10,418	9,468	9,300
EBITDA Margin	17.90%	16.03%	10.32%	11.80%	12.11%	13.27%
D&A For EBITDA	2,429	2,594	2,498	2,561	2,360	2,130
EBIT	16,744	13,691	6,629	7,857	7,108	7,171
EBIT Margin	15.63%	13.48%	7.49%	8.90%	9.09%	10.23%
Effective Tax Rate	14.68%	13.86%	16.37%	-	13.01%	19.79%
Advertising Expenses	-	2,099	1,999	1,695	804.23	820.39

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.